Scientist, Analytical & Formulation Development

Technical Operations South San Francisco, California


Description

Sutro Biopharma, Inc. is seeking a driven and talented Scientist to join our Analytical Development team as we change the future of oncology. This role will support chromatography assay development for monoclonal antibodies, bispecific antibodies, cytokines, and antibody drug conjugates. While collaborating with cross-functional departments, you will play a key role in maximizing our technology and progressing our novel therapeutics. We are dedicated to making a difference in the lives of patients, both as individuals and as part of a team. 

Responsibilities:

  • Develop new chromatography assays for characterization of recombinant proteins and conjugates.
  • Perform testing to support upstream/downstream development, formulation development, and manufacturing.
  • Qualify assays and support technology transfer to Sutro QC and contract testing laboratories.
  • Author and review SOPs, protocols, and technical reports.
  • Work collaboratively within Analytical Development, other functional areas, external partners, and CMOs.
  • Perform routine maintenance and troubleshoot instrumentation. 

Qualifications:

  • PhD in analytical chemistry, biochemistry, molecular biology or related scientific field and 2+ years of industry experience in the characterization of large molecule biologics is required OR
  • BS/MS in analytical chemistry, biochemistry, molecular biology or related scientific field and 6+ years of industry experience in the characterization of large molecule biologics is required.
  • Requires expertise in analytical chromatography and electrophoresis of recombinant proteins modes including SEC, IEC, RPLC, icIEF, and CE-SDS.
  • A thorough understanding of protein separation methods combined with the experience in developing, qualifying methods, and transferring assays to QC environment is required.
  • Experience in developing analytical methods for small molecules and polymers is desired.
  • Knowledge of mass spectrometry is highly preferred.
  • Demonstrated leadership ability, including a commitment to mentorship and development of personnel.
  • Flexibility to work on multiple projects in a fast-paced environment is essential.
  • Good communication skills are essential. 

Sound exciting? Apply today and join our team!

Sutro Biopharma, Inc. encourages all colleagues to be fully vaccinated for COVID-19 prior to the first date of employment.   


As an equal opportunity employer, we believe in fostering a culture that is inclusive and values diversity in background and opinions. Sutro Biopharma hires extraordinary individuals into every position in the company and is committed to the diversity of our team. Our company progresses without regard of race, ethnicity, gender, sexual orientation, religious belief, age, disability or citizenship status. We are dedicated to creating a safe environment where our employees can grow and succeed together.   

We look forward to hearing from candidates who are interested in exploring opportunities with Sutro! Our People & Culture team/hiring managers are unable to respond and do not accept solicitations from third-party agencies.   

The anticipated salary range for fully qualified candidates applying for this role at Sutro Biopharma’s California-based locations will be $134,000 - $169,000. The final salary offered will be dependent on several factors that include and are not limited to relevant previous experience, job responsibilities and duration of experience, the type and length of experience within the industry, and education.   

About Sutro Biopharma    

Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.